Literature DB >> 19470672

Anti-IL-2 receptor antibodies versus anti-thymocyte globulin for induction therapy in kidney transplantation.

Didier Mandelbrot.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19470672     DOI： 10.1681/ASN.2009040389

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  3 in total

Review 1.  Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Authors:  J Khosla; A C Yeh; T R Spitzer; B R Dey
Journal:  Bone Marrow Transplant       Date:  2017-10-02       Impact factor: 5.483

2.  Heterogeneity of induction therapy in Spain: changing patterns according to year, centre, indications and results.

Authors:  Emilio Rodrigo; Gema Fernández-Fresnedo; Carmen Robledo; Rosa Palomar; Carmen Cantarell; Auxiliadora Mazuecos; Antonio Osuna; Alicia Mendiluce; Antonio Alarcón; Manuel Arias
Journal:  NDT Plus       Date:  2010-06

3.  Rabbit anti-thymocyte globulin (rATG) versus IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis.

Authors:  Hatem Ali; Karim M Soliman; Ihab Shaheen; Jon Jin Kim; Mohsen El Kossi; Ajay Sharma; Ravi Pararajasingam; Ahmed Halawa
Journal:  Int Urol Nephrol       Date:  2020-03-13       Impact factor: 2.370
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.